News

Camurus, Eli Lilly Collaborate for Long-Acting Incretin Products Using FluidCrystal Technology
Camurus (OTC:CAMRF) and Eli Lilly and Company (NYSE:LLY) entered into a collaboration and license agreement. This agreement grants Lilly exclusive, worldwide rights to research, develop, manufacture, ...
Mounjaro Maker Eli Lilly Taps Swedish Firm Camurus To Target Long-Acting Obesity Market In $870-Million Deal
Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies ...
Hosted on MSN3mon
Eli Lilly wants to use its weight loss drug windfall to fight Alzheimer's and hearing loss
Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen in the background in this illustration photo taken in Krakow, Poland on November 10, 2022. The weight ...
Forbes1y
Pharmaceutical First: Eli Lilly Website Will Prescribe Weight Loss Drugs Through Service
Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen. Called LillyDirect, the new website is the first of its kind from a pharmaceutical company and will ...